Odyssey Therapeutics
(NASDAQ) ODTX
Odyssey Therapeutics Financials at a Glance
Market Cap
$764.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$3.67
Net Income (TTM)
-$112.63
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.34 (Low)
Dividend
$0.00
Beta (Volatility)
-0.34 (Low)
Price
$15.91
Volume
229,331
Open
$16.65
Price
$15.91
Volume
229,331
Open
$16.65
Previous Close
$15.91
Daily Range
$15.59 - $16.82
52-Week Range
$15.35 - $20.30
Estimated Earnings Date
Sep 16, 2026
Dividend
$0.00
Beta (Volatility)
-0.34 (Low)
Price
$15.91
Volume
229,331
Open
$16.65
Previous Close
$15.91
Daily Range
$15.59 - $16.82
52-Week Range
$15.35 - $20.30
Estimated Earnings Date
Sep 16, 2026
ODTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Odyssey Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Gary D. Glick, PhD
Website
www.odysseytx.comHeadquarters
Boston, MA 02210, US
ODTX Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-5415.19%
Net Income Margin
-4994.86%
Return on Equity
30.44%
Return on Capital
N/A
Return on Assets
-55.10%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$764.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
48.03M
Volume
229.33K
Avg. Volume
415.85K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$39.78M
EBITDA
-$37.02M
Operating Cash Flow
-$41.04M
Capital Expenditure
-$148.00K
Free Cash Flow
-$41.18M
Cash & ST Invst.
$175.75M
Total Debt
$26.13M
Odyssey Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$764.18MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$7.64M
N/A
Employees
100
N/A
Net Income
-$38.26M
N/A
EBITDA
-$37.02M
N/A
Quarterly Fundamentals
Total Cash
$175.75M
N/A
Total Debt
$26.13M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$20.75M
N/A
Short Term Debt
$5.37M
N/A
Return on Assets
-55.10%
N/A
Return on Invested Capital
-66.23%
N/A
Free Cash Flow
-$41.18M
N/A
Operating Cash Flow
-$41.04M
N/A